Influence of Sugar Amine Regiochemistry on Digitoxigenin Neoglycoside Anticancer Activity.

The synthesis of a set of digitoxigenin neogluco/xylosides and corresponding study of their anticancer SAR revealed sugar amine regiochemistry has a dramatic effect upon activity. Specifically, this study noted sugar 3-amino followed by 4-amino-substitution to be most advantageous where the solvent accessibility of the appended amine within neoglycoside-Na(+),K(+)-ATPase docked models correlated with increased anticancer potency. This study presents a preliminary model for potential further warhead optimization in the context of antibody-directed steroidal glycosides and extends the demonstrated compatibility of aminosugars in the context of neoglycosylation.

[1]  P. Nissen,et al.  Structures and characterization of digoxin- and bufalin-bound Na+,K+-ATPase compared with the ouabain-bound complex , 2015, Proceedings of the National Academy of Sciences.

[2]  Q. She,et al.  The Identification of Perillyl Alcohol Glycosides with Improved Antiproliferative Activity , 2014, Journal of medicinal chemistry.

[3]  Randal D Goff,et al.  Neoglycosylation and neoglycorandomization: Enabling tools for the discovery of novel glycosylated bioactive probes and early stage leads. , 2014, MedChemComm.

[4]  M. López-Lázaro,et al.  The in vivo antitumor activity of cardiac glycosides in mice xenografted with human cancer cells is probably an experimental artifact , 2014, Oncogene.

[5]  M. López-Lázaro,et al.  Evaluating the Cancer Therapeutic Potential of Cardiac Glycosides , 2014, BioMed research international.

[6]  J. Thorson,et al.  A Simple Strategy for Glycosyltransferase‐Catalyzed Aminosugar Nucleotide Synthesis , 2014, Chembiochem : a European journal of chemical biology.

[7]  C. Dinu,et al.  Monosaccharide digitoxin derivative sensitize human non-small cell lung cancer cells to anoikis through Mcl-1 proteasomal degradation. , 2014, Biochemical pharmacology.

[8]  E. Rosenthal,et al.  A novel extracellular drug conjugate significantly inhibits head and neck squamous cell carcinoma. , 2013, Oral oncology.

[9]  J. Thorson,et al.  Synthesis and antibacterial activity of doxycycline neoglycosides. , 2013, Journal of natural products.

[10]  G. Figtree,et al.  Redox-dependent regulation of the Na⁺-K⁺ pump: new twists to an old target for treatment of heart failure. , 2013, Journal of molecular and cellular cardiology.

[11]  P. Nissen,et al.  Crystal structure of the high-affinity Na+,K+-ATPase–ouabain complex with Mg2+ bound in the cation binding site , 2013, Proceedings of the National Academy of Sciences.

[12]  H. Gelderblom,et al.  Cardiac glycosides in cancer therapy: from preclinical investigations towards clinical trials , 2013, Investigational New Drugs.

[13]  Mark S. Taylor,et al.  Synthesis of cardiac glycoside analogs by catalyst-controlled, regioselective glycosylation of digitoxin. , 2013, Organic letters.

[14]  L. Zitvogel,et al.  Trial watch , 2013, Oncoimmunology.

[15]  N. Akhmedov,et al.  C3′/C4′‐Stereochemical Effects of Digitoxigenin α‐L‐/α‐D‐Glycoside in Cancer Cytotoxicity , 2013, ChemMedChem.

[16]  J. Thorson,et al.  Natural product disaccharide engineering through tandem glycosyltransferase catalysis reversibility and neoglycosylation. , 2012, Organic letters.

[17]  T. Kawabata,et al.  Regioselective diversification of a cardiac glycoside, lanatoside C, by organocatalysis. , 2012, The Journal of organic chemistry.

[18]  L. Zitvogel,et al.  Cardiac Glycosides Exert Anticancer Effects by Inducing Immunogenic Cell Death , 2012, Science Translational Medicine.

[19]  E. Diamandis,et al.  Digitoxin-Induced Cytotoxicity in Cancer Cells Is Mediated through Distinct Kinase and Interferon Signaling Networks , 2011, Molecular Cancer Therapeutics.

[20]  Y. Rojanasakul,et al.  C5'-Alkyl Substitution Effects on Digitoxigenin α-l-Glycoside Cancer Cytotoxicity. , 2011, ACS medicinal chemistry letters.

[21]  Y. Rojanasakul,et al.  Synthesis and Evaluation of the α-d-/α-l-Rhamnosyl and Amicetosyl Digitoxigenin Oligomers as Antitumor Agents , 2011 .

[22]  Y. Rojanasakul,et al.  Stereochemical survey of digitoxin monosaccharides: new anticancer analogues with enhanced apoptotic activity and growth inhibitory effect on human non-small cell lung cancer cell. , 2011, ACS medicinal chemistry letters.

[23]  Derek K. Rogalsky,et al.  A Direct Comparison of the Anticancer Activities of Digitoxin MeON-Neoglycosides and O-Glycosides: Oligosaccharide Chain Length-Dependent Induction of Caspase-9-Mediated Apoptosis. , 2010, ACS medicinal chemistry letters.

[24]  L. Bohlin,et al.  Cytotoxic effects of cardiac glycosides in colon cancer cells, alone and in combination with standard chemotherapeutic drugs. , 2009, Journal of natural products.

[25]  Eleftherios P. Diamandis,et al.  Novel therapeutic applications of cardiac glycosides , 2008, Nature Reviews Drug Discovery.

[26]  Robert A Newman,et al.  Cardiac glycosides as novel cancer therapeutic agents. , 2008, Molecular interventions.

[27]  K. Winnicka,et al.  Apoptosis-mediated cytotoxicity of ouabain, digoxin and proscillaridin A in the estrogen independent MDA-MB-231 breast cancer cells , 2007, Archives of pharmacal research.

[28]  R. Kiss,et al.  Cardiotonic steroids on the road to anti-cancer therapy. , 2007, Biochimica et biophysica acta.

[29]  Lijun Liu,et al.  Identification of a Pool of Non-pumping Na/K-ATPase* , 2007, Journal of Biological Chemistry.

[30]  A. Andres,et al.  Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5. , 2006, Cancer research.

[31]  R. Kiss,et al.  Cardenolide-induced lysosomal membrane permeabilization demonstrates therapeutic benefits in experimental human non-small cell lung cancers. , 2006, Neoplasia.

[32]  Xin-Yun Huang,et al.  Binding of Src to Na+/K+-ATPase forms a functional signaling complex. , 2005, Molecular biology of the cell.

[33]  Zijian Xie,et al.  The Na/K-ATPase-mediated signal transduction as a target for new drug development. , 2005, Frontiers in bioscience : a journal and virtual library.

[34]  F. Hoffmann,et al.  Enhancing the anticancer properties of cardiac glycosides by neoglycorandomization. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Lijun Liu,et al.  Digitalis-Induced Signaling by Na+/K+-ATPase in Human Breast Cancer Cells , 2005, Molecular Pharmacology.

[36]  G. Bianchi,et al.  Organ Hypertrophic Signaling within Caveolae Membrane Subdomains Triggered by Ouabain and Antagonized by PST 2238* , 2004, Journal of Biological Chemistry.

[37]  P. S. Wang,et al.  Inhibitory effects of digitalis on the proliferation of androgen dependent and independent prostate cancer cells. , 2001, The Journal of urology.

[38]  L. Bohlin,et al.  Cytotoxicity of digitoxin and related cardiac glycosides in human tumor cells , 2001, Anti-cancer drugs.

[39]  Kai Simons,et al.  Lipid rafts and signal transduction , 2000, Nature Reviews Molecular Cell Biology.

[40]  L. Nutt,et al.  Cardiac glycosides stimulate Ca2+ increases and apoptosis in androgen-independent, metastatic human prostate adenocarcinoma cells. , 2000, Cancer research.

[41]  J. Haux.  Digitoxin is a potential anticancer agent for several types of cancer. , 1999, Medical hypotheses.

[42]  B. Stenkvist.  Is digitalis a therapy for breast carcinoma? , 1999, Oncology reports.

[43]  K. Repke.  Toward the discovery of digitalis derivatives with inotropic selectivity , 1997 .

[44]  Abe. J. Goldin,et al.  DIGITALIS AND CANCER , 1984, The Lancet.

[45]  E. Bengtsson,et al.  Cardiac glycosides and breast cancer, revisited. , 1982, The New England journal of medicine.

[46]  G. Eklund,et al.  CARDIAC GLYCOSIDES AND BREAST CANCER , 1979, The Lancet.

[47]  D. Greenblatt,et al.  Inotropic and Toxic Effects of a Polar Cardiac Glycoside Derivative in the Dog , 1978, Circulation research.

[48]  R. Caldwell,et al.  Pharmacological studies of a new 4-aminosugar cardiac glycoside (ASI-222). , 1976, The Journal of pharmacology and experimental therapeutics.

[49]  Z. Braf,et al.  TOXICITY OF COLLINS SOLUTION , 1974 .

[50]  P. Nissen,et al.  Na+,K+-ATPase as a docking station: protein–protein complexes of the Na+,K+-ATPase , 2012, Cellular and Molecular Life Sciences.

[51]  Liying Wang,et al.  Digitoxin and a synthetic monosaccharide analog inhibit cell viability in lung cancer cells. , 2012, Toxicology and applied pharmacology.

[52]  G. O'Doherty,et al.  The de novo synthesis of oligosaccharides: application to the medicinal chemistry SAR-study of digitoxin. , 2008, Current topics in medicinal chemistry.

[53]  Zijian Xie,et al.  The Na/K-ATPase/Src complex and cardiotonic steroid-activated protein kinase cascades , 2008, Pflügers Archiv - European Journal of Physiology.